Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.63K Sell
143
-85
-37% -$5.66K ﹤0.01% 303
2026
Q1
$14.3K Buy
228
+36
+19% +$2.51K 0.01% 251
2025
Q4
$12.7K Buy
192
+98
+104% +$6.34K ﹤0.01% 231
2025
Q3
$6.33K Buy
94
+71
+309% +$5.62K ﹤0.01% 295
2025
Q2
$2.01K Sell
23
-10
-30% -$784 ﹤0.01% 384
2025
Q1
$2.25K Buy
+33
New +$2.69K ﹤0.01% 302

Other funds holding DXCM

S&T Bank's DXCM Position: Q2 2026 in Review

S&T Bank reduced its DexCom (DXCM) stake by 37% in Q2 2026, selling an estimated $5.66K and leaving 143 shares worth $9.63K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

S&T Bank first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.3K in Q1 2026. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • S&T Bank held 143 shares of DexCom worth $9.63K as of Q2 2026.
  • S&T Bank sold 85 DexCom shares in Q2 2026, an estimated $5.66K.
  • DexCom made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #303 holding.
  • S&T Bank first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
  • S&T Bank's DexCom position peaked at $14.3K in Q1 2026.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.